Evidence map›Paper›PMID 34440265›Full record

ReviewBiomedicines2021

Exosomes: Potential Disease Biomarkers and New Therapeutic Targets.

Maria I Mosquera-Heredia, Luis C Morales, Oscar M Vidal, Ernesto Barceló, Carlos Silvera-Redondo, Jorge I Vélez, Pilar Garavito-Galofre

Abstract readReview
In one paragraph

Review in Biomedicines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 95 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
95citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

95 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article

35 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Maria I Mosquera-HerediaDepartment of Medicine, Universidad del Norte, Barranquilla 081007, Colombia.ORCID 0000-0002-9662-2925
Luis C MoralesDepartment of Medicine, Universidad del Norte, Barranquilla 081007, Colombia.
Oscar M VidalDepartment of Medicine, Universidad del Norte, Barranquilla 081007, Colombia.
Ernesto BarcelóInstituto Colombiano de Neuropedagogía, Barranquilla 080020, Colombia.
Carlos Silvera-RedondoDepartment of Medicine, Universidad del Norte, Barranquilla 081007, Colombia.
Jorge I VélezDepartment of Industrial Engineering, Universidad del Norte, Barranquilla 081007, Colombia.ORCID 0000-0002-3146-7899
Pilar Garavito-GalofreDepartment of Medicine, Universidad del Norte, Barranquilla 081007, Colombia.

Funding

Ministerio de Ciencia, Tecnología e Innovación de Colombia. Minciencias grant 844/2019, contract 1369 416-2020
6 · The paper itself

Abstract

Exosomes are extracellular vesicles released by cells, both constitutively and after cell activation, and are present in different types of biological fluid. Exosomes are involved in the pathogenesis of diseases, such as cancer, neurodegenerative diseases, pregnancy disorders and cardiovascular diseases, and have emerged as potential non-invasive biomarkers for the detection, prognosis and therapeutics of a myriad of diseases. In this review, we describe recent advances related to the regulatory mechanisms of exosome biogenesis, release and molecular composition, as well as their role in health and disease, and their potential use as disease biomarkers and therapeutic targets. In addition, the advantages and disadvantages of their main isolation methods, characterization and cargo analysis, as well as the experimental methods used for exosome-mediated drug delivery, are discussed. Finally, we present potential perspectives for the use of exosomes in future clinical practice.

Indexed as

biogenesisbiomarkerexosomeintercellular communicationtherapeutic vehicle

Identifiers

PMID34440265
PMCPMC8393483

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.